CPIM
EBS icon

Columbia Partners Investment Management’s Emergent Biosolutions EBS Stock Holding History

Columbia Partners Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-72,115
Closed -$2.62M – 345
2016
Q1 		$2.62M Buy
+72,115
New +$2.55M 0.19% 150
2015
Q4 		– Sell
-56,673
Closed -$1.61M – 348
2015
Q3 		$1.61M Sell
56,673
-16,606
-23% -$547K 0.11% 202
2015
Q2 		$2.41M Sell
73,279
-37,492
-34% -$1.16M 0.15% 173
2015
Q1 		$3.19M Buy
+110,771
New +$3.18M 0.17% 164

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Columbia Partners Investment Management's EBS Position: Q2 2016 in Review

Columbia Partners Investment Management sold out of Emergent Biosolutions (EBS) in Q2 2016, closing a stake of 72,115 shares — an estimated $2.62M sold.

Columbia Partners Investment Management first reported a position in EBS in Q1 2015 and held it in 4 quarters. The position peaked at $3.19M in Q1 2015. 225 funds tracked by Wall St. Rank hold EBS as of Q2 2016.

  • Columbia Partners Investment Management reported no remaining Emergent Biosolutions position as of Q2 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 72,115 Emergent Biosolutions shares in Q2 2016, an estimated $2.62M.
  • Columbia Partners Investment Management first reported a position in Emergent Biosolutions in Q1 2015 and held it in 4 quarters.
  • Columbia Partners Investment Management's Emergent Biosolutions position peaked at $3.19M in Q1 2015.
  • 225 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2016.

Based on Columbia Partners Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.